Sort
8,912 grants matching “sars cov 2”
NETs: Protection or Harm in Neonatal Inflammation and Infection
$501,139Christian Con Yost · Utah State Higher Education System--University Of Utah · R01 · FY2025 · HD
Sex differences in hypertension, cognitive function and renal hemodynamics; a role for B cells and autoantibodies
$501,050Babbette Babbette Lamarca · University Of Mississippi Med Ctr · R01 · FY2025 · HL
Sex differences in hypertension, cognitive function and renal hemodynamics; a role for B cells and autoantibodies
$501,050Babbette Babbette Lamarca · University Of Mississippi Med Ctr · R01 · FY2024 · HL
A Web Service for Fragment-based Selectivity Analysis of Drug Leads
$500,765John Laurence Kulp III · Conifer Point Pharmaceuticals, Llc · R44 · FY2024 · GM
Neutralization of primary HIV-1 viruses
$500,527John P Moore · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · AI
Neutralization of primary HIV-1 viruses
$500,527John P Moore · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · AI
Neutralization of primary HIV-1 viruses
$500,527John P Moore · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · AI
Clinical Core
$500,514Matthew Hamill · Johns Hopkins University · U54 · FY2024 · EB
Age related loss of immune resilience during response to severe respiratory viral infections
$500,424Leopoldo Nicolas Segal · New York University School Of Medicine · U01 · FY2025 · AG
Exosome-based Non-traditional Technologies Towards Multi-Parametric andIntegrated Approaches for SARS-CoV-2
$500,000Samarjit Das · Johns Hopkins University · U18 · FY2022 · TR
A modular platform for rapid VLP vaccine development and manufacturing for SARS-CoV-2 pandemic response
$500,000Stacy Springs · Massachusetts Institute Of Technology · R01 · FY2023 · FD
A modular platform for rapid VLP vaccine development and manufacturing for SARS-CoV-2 pandemic response
$500,000Stacy Springs · Massachusetts Institute Of Technology · R01 · FY2022 · FD
A modular platform for rapid VLP vaccine development and manufacturing for SARS-CoV-2 pandemic response
$500,000Stacy Springs · Massachusetts Institute Of Technology · R01 · FY2021 · FD
IP21-002, Enhanced Surveillance Network for Enteric and Respiratory Viruses in Children: Assessing Disease Burden, Natural History, and Vaccine Effectiveness
$500,000Geoffrey Alan Weinberg · University Of Rochester · U01 · FY2025 · IP
RFA-GH-21-006, SICA Study: Seroepidemiological Insight into COVID-19 transmission in Africa
$500,000Rhoel David Ramos Dinglasan · University Of Florida · U01 · FY2022 · GH
A multimodal platform for Oral screening of COVID-19
$500,000Roya Khosravi-Far · Innotech Precision Medicine, Inc · R42 · FY2022 · DE
Rolosense: An innovative platform for automatic mobile phone readout of active SARS-CoV-2 particles (RADx-rad / SEED Administrative Supplement)
$500,000Khalid S. Salaita · Emory University · U01 · FY2022 · AA
Antiviral Program for Pandemics (APP) & NCATS: Accelerating Antiviral Development
$500,000Matthew Hall · National Center For Advancing Translational Sciences · ZIA · FY2024 · TR
Role of Kidney Proximal Tubular Secretion in Critical Illness
$500,000Bryan R Kestenbaum · University Of Washington · R01 · FY2020 · DK
Division of Microbiology and Infectious Diseases (DMID): Clinical Materials Services (CMS), SARS-CoV-2
$500,000Dennis Eyler · Fisher Bioservices, Inc. · N01 · FY2024 · AI
CAREER: Rational Design of One-Dimensional Contacts to Two-Dimensional Atomically Thin Heterostructure for High-Performance and Low Noise Field Effect Transistors and Biosensors
$500,000Suprem R Das · Kansas State University · · FY2022 · ENG
RCN: Wastewater Surveillance for SARS-CoV-2 and Emerging Public Health Threats
$500,000Kyle Bibby · University Of Notre Dame · · FY2022 · ENG
CAREER: Wastewater Counts: Real-time de facto Population Estimation for Quantitative Wastewater-based Epidemiology
$500,000Fangqiong Ling · Washington University · · FY2021 · ENG
MOdeling Nursing homes to Affect Response to COVID-19 (MONARC)
$500,000Bruce Y Lee · Graduate School Of Public Health And Health Policy · R01 · FY2021 · HS
The Experiences of Ethnic Minorities, and those with Liver Disease, during COVID-19, and The Impact on Related Health and Prevention Behaviors
$500,000Yasmin Ibrahim · Hepatitis B Foundation · U01 · FY2023 · FD